Advertisement

Topics

Dr. Reddy's Laboratories Announces the Out-Licensing of DFD-06 to Encore Dermatology

01:50 EDT 22 Aug 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY), through its wholly owned subsidiary Promius Pharma, LLC, announced today that it has out-licensed the future development, manufacturing, and commercializati...

Other Sources for this Article

Dr. Reddy’s Laboratories Ltd.
INVESTOR RELATIONS
SAUNAK SAVLA
(Ph: +91-40-49002135)
saunaks@drreddys.com
or
MEDIA RELATIONS
CALVIN PRINTER
(Ph: +91-40- 49002121)
calvinprinter@drreddys.com

NEXT ARTICLE

More From BioPortfolio on "Dr. Reddy's Laboratories Announces the Out-Licensing of DFD-06 to Encore Dermatology"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Dermatology
Acne Dermatology Eczema Psoriasis Wound Care Dermatology is the medical specialty concerned with the diagnosis and treatment of skin disorders (Oxford Medical Dictionary). As well as studying how the skin works, dermatology covers...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...